These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21311309)

  • 1. Optimal size range for enteric-coated pancreatin preparations.
    Lederer PC
    Pancreas; 2011 Mar; 40(2):310-1. PubMed ID: 21311309
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH values.
    Gan KH; Geus WP; Bakker W; Lamers CB; Heijerman HG
    Aliment Pharmacol Ther; 1996 Oct; 10(5):771-5. PubMed ID: 8899086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency.
    Halm U; Löser C; Löhr M; Katschinski M; Mössner J
    Aliment Pharmacol Ther; 1999 Jul; 13(7):951-7. PubMed ID: 10383531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS.
    Maev IV; Kucheryavyy YA; Gubergrits NB; Bonnacker I; Shelest EA; Janssen-van Solingen GP; Domínguez-Muñoz JE
    Drugs R D; 2020 Dec; 20(4):369-376. PubMed ID: 33211277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
    Trang T; Chan J; Graham DY
    World J Gastroenterol; 2014 Sep; 20(33):11467-85. PubMed ID: 25206255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of pellet size of a pancreas enzyme preparation on duodenal lipolytic activity].
    Kühnelt P; Mundlos S; Adler G
    Z Gastroenterol; 1991 Sep; 29(9):417-21. PubMed ID: 1763562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
    Dutta SK; Tilley DK
    J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy.
    Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Gulik TM; de Wit LT; Gouma DJ; van Leeuwen DJ; Tytgat GN
    Br J Surg; 1997 Jul; 84(7):952-6. PubMed ID: 9240133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PANCREATIC EXOCRINE INSUFFICIENCY AND ITS CORRECTION IN CHILDREN WITH TYPE I DIABETES IN COMBINATION WITH CELIAC DISEASE].
    Bolshova EV; Lukashuk IV; Lukashuk VD
    Lik Sprava; 2015; (1-2):167-9. PubMed ID: 26118067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test.
    Mundlos S; Kühnelt P; Adler G
    Gut; 1990 Nov; 31(11):1324-8. PubMed ID: 2253920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
    Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
    Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?
    Domínguez-Muñoz JE
    Adv Med Sci; 2011; 56(1):1-5. PubMed ID: 21450558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pancreatic exocrine deficiency.
    Sarner M
    World J Surg; 2003 Nov; 27(11):1192-5. PubMed ID: 14534818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of pancreatic Schilling test to determine efficiency of pancreatic enzyme delivery in pancreatic insufficiency.
    Brugge WR; Goldberg HJ; Burke CA; Depping BJ
    Dig Dis Sci; 1988 Oct; 33(10):1226-32. PubMed ID: 3168695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Piehl S; Brinkmann R; Windeck T
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):635-6; author reply 636-7. PubMed ID: 20393298
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation and in vivo efficacy study of pancreatin microparticles as an enzyme replacement therapy for pancreatitis.
    Naikwade SR; Meshram RN; Bajaj AN
    Drug Dev Ind Pharm; 2009 Apr; 35(4):417-32. PubMed ID: 18850362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of panzytrat--modern physiological enzyme preparation in complex therapy of pancreatic exocrine secretory insufficiency in cholelithiasis].
    Petukhov VA; Mironov AV; Semenov ZhS; Ustinov FS
    Eksp Klin Gastroenterol; 2009; (1):72-80. PubMed ID: 19551960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.